Literature DB >> 25577182

Substance use disorders in individuals with mild to borderline intellectual disability: current status and future directions.

Neomi van Duijvenbode1, Joanneke E L VanDerNagel2, Robert Didden3, Rutger C M E Engels4, Jan K Buitelaar5, Marion Kiewik6, Cor A J de Jong7.   

Abstract

Knowledge regarding substance use (SU) and substance use disorder (SUD) in individuals with mild to borderline intellectual disabilities (ID) has increased over the last decade, but is still limited. Data on prevalence and risk factors are fragmented, and instruments for screening and assessment and effective treatment interventions are scarce. Also, scientific developments in other fields are insufficiently incorporated in the care for individuals with ID and SUD. In this selective and critical review, we provide an overview of the current status of SU(D) in ID and explore insights on the conceptualisation of SUD from other fields such as addiction medicine and general psychiatry. SU(D) turns out to be a chronic, multifaceted brain disease that is intertwined with other physical, psychiatric and social problems. These insights have implications for practices, policies and future research with regard to the prevalence, screening, assessment and treatment of SUD. We will therefore conclude with recommendations for future research and policy and practice, which may provide a step forward in the care for individuals with ID and SUD.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Assessment; Intellectual disability; Prevalence; Screening; Substance use disorder; Treatment

Mesh:

Year:  2015        PMID: 25577182     DOI: 10.1016/j.ridd.2014.12.029

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  16 in total

1.  Primary care of adults with intellectual and developmental disabilities: 2018 Canadian consensus guidelines.

Authors:  William F Sullivan; Heidi Diepstra; John Heng; Shara Ally; Elspeth Bradley; Ian Casson; Brian Hennen; Maureen Kelly; Marika Korossy; Karen McNeil; Dara Abells; Khush Amaria; Kerry Boyd; Meg Gemmill; Elizabeth Grier; Natalie Kennie-Kaulbach; Mackenzie Ketchell; Jessica Ladouceur; Amanda Lepp; Yona Lunsky; Shirley McMillan; Ullanda Niel; Samantha Sacks; Sarah Shea; Katherine Stringer; Kyle Sue; Sandra Witherbee
Journal:  Can Fam Physician       Date:  2018-04       Impact factor: 3.275

2. 

Authors:  William F Sullivan; Heidi Diepstra; John Heng; Shara Ally; Elspeth Bradley; Ian Casson; Brian Hennen; Maureen Kelly; Marika Korossy; Karen McNeil; Dara Abells; Khush Amaria; Kerry Boyd; Meg Gemmill; Elizabeth Grier; Natalie Kennie-Kaulbach; Mackenzie Ketchell; Jessica Ladouceur; Amanda Lepp; Yona Lunsky; Shirley McMillan; Ullanda Niel; Samantha Sacks; Sarah Shea; Katherine Stringer; Kyle Sue; Sandra Witherbee
Journal:  Can Fam Physician       Date:  2018-04       Impact factor: 3.275

3.  A Systematic Review of Substance Use (Disorder) in Individuals with Mild to Borderline Intellectual Disability.

Authors:  Neomi van Duijvenbode; Joanne E L VanDerNagel
Journal:  Eur Addict Res       Date:  2019-07-22       Impact factor: 3.015

4.  A national profile of substance use disorder among Medicaid enrollees on the autism spectrum or with intellectual disability.

Authors:  Anne M Roux; Sha Tao; Steven Marcus; Viktor Lushin; Lindsay L Shea
Journal:  Disabil Health J       Date:  2022-03-07       Impact factor: 4.615

5.  Evaluating a personalized treatment for substance use disorder in people with mild intellectual disability or borderline intellectual functioning: A study protocol of a multiple baseline across individuals design.

Authors:  Lotte C F Gosens; Roy Otten; Robert Didden; Evelien A P Poelen
Journal:  Contemp Clin Trials Commun       Date:  2020-07-16

6.  Substance-related and addictive disorders among adults with intellectual and developmental disabilities (IDD): an Ontario population cohort study.

Authors:  Elizabeth Lin; Robert Balogh; Caitlin McGarry; Avra Selick; Kristin Dobranowski; Andrew S Wilton; Yona Lunsky
Journal:  BMJ Open       Date:  2016-09-02       Impact factor: 2.692

7.  A Blind Spot? Screening for Mild Intellectual Disability and Borderline Intellectual Functioning in Admitted Psychiatric Patients: Prevalence and Associations with Coercive Measures.

Authors:  Jeanet Grietje Nieuwenhuis; Eric Onno Noorthoorn; Henk Llewellyn Inge Nijman; Paul Naarding; Cornelis Lambert Mulder
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

8.  Psychiatric diagnoses in older people with intellectual disability in comparison with the general population: a register study.

Authors:  A Axmon; P Björne; L Nylander; G Ahlström
Journal:  Epidemiol Psychiatr Sci       Date:  2017-02-23       Impact factor: 6.892

9.  The occurrence of comorbidities with affective and anxiety disorders among older people with intellectual disability compared with the general population: a register study.

Authors:  Nadia El Mrayyan; Jonas Eberhard; Gerd Ahlström
Journal:  BMC Psychiatry       Date:  2019-06-03       Impact factor: 3.630

10.  Substance use problems among people with mild/borderline intellectual disability: Challenges to mainstream multidisciplinary specialist substance treatment in Norway.

Authors:  Anne Juberg; Monica Røstad; Erik Søndenaa
Journal:  Nordisk Alkohol Nark       Date:  2017-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.